-
1
-
-
0029895509
-
Screening for ovarian cancer
-
Fiorica JV and Roberts WS: Screening for ovarian cancer. Cancer Control 3: 120-129, 1996. (Pubitemid 26162154)
-
(1996)
Cancer Control
, vol.3
, Issue.2
, pp. 120-129
-
-
Fiorica, J.V.1
Roberts, W.S.2
-
2
-
-
0141688377
-
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study
-
DOI 10.1200/JCO.2003.02.153
-
Ozols RF, Bundy BN, Greer BE, et al: Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group Study. J Clin Oncol 21: 3194-3200, 2003. (Pubitemid 46606249)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.17
, pp. 3194-3200
-
-
Ozols, R.F.1
Bundy, B.N.2
Greer, B.E.3
Fowler, J.M.4
Clarke-Pearson, D.5
Burger, R.A.6
Mannel, R.S.7
DeGeest, K.8
Hartenbach, E.M.9
Baergen, R.10
Mackey, D.11
-
3
-
-
7844240130
-
Chemotherapy in advanced ovarian cancer: Four systematic meta-analyses of individual patient data from 37 randomized trials
-
Aabo K, Adam SM, Adnitt P, et al: Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group. Br J Cancer 78: 1479-1487, 1998. (Pubitemid 28517545)
-
(1998)
British Journal of Cancer
, vol.78
, Issue.11
, pp. 1479-1487
-
-
Aabo, K.1
Adams, M.2
Adnitt, P.3
Alberts, D.S.4
Athanazziou, A.5
Barley, V.6
Bell, D.R.7
Bianchi, U.8
Bolis, G.9
Brady, M.F.10
Brodovsky, H.S.11
Bruckner, H.12
Buyse, M.13
Canetta, R.14
Chylak, V.15
Cohen, C.J.16
Colombo, N.17
Conte, P.F.18
Crowther, D.19
Edmonson, J.H.20
Gennatas, C.21
Gilbey, E.22
Gore, M.23
Guthrie, D.24
Kaye, S.B.25
Laing, A.H.26
Landoni, F.27
Leonard, R.C.28
Lewis, C.29
Liu, P.Y.30
Mangioni, C.31
Marsoni, S.32
Meerpohl, H.33
Omura, G.A.34
Parmar, M.K.B.35
Pater, J.36
Pecorelli, S.37
Presti, M.38
Sauerbrei, W.39
Skarlos, D.V.40
Smalley, R.V.41
Solomon, H.J.42
Stewart, L.A.43
Sturgeon, J.F.G.44
Tattersall, M.H.N.45
Wharton, J.T.46
Ten, B.H.W.W.47
Tomirotti, M.48
Torri, W.49
Trope, C.50
Turbow, M.M.51
Vermorken, J.B.52
Webb, M.J.53
Wilbur, D.W.54
Williams, C.J.55
Wiltshaw, E.56
Yeap, B.Y.57
more..
-
4
-
-
0037440295
-
Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European organisation for research and treatment of cancer-adjuvant chemotherapy in ovarian neoplasm-trial
-
Trimbos JB, Vergote I, Bolis G, et al: European Organisation for Research and Treatment of Cancer-Adjuvant Chemotherapy in Ovarian Neoplasm. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant Chemotherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 95: 113-125, 2003. (Pubitemid 36193260)
-
(2003)
Journal of the National Cancer Institute
, vol.95
, Issue.2
, pp. 113-125
-
-
Trimbos, J.B.1
Vergote, I.2
Bolis, G.3
Vermorken, J.B.4
Mangioni, C.5
Madronal, C.6
Franchi, M.7
Tateo, S.8
Zanetta, G.9
Scarfone, G.10
Giurgea, L.11
Trimmers, P.12
Coens, C.13
Pecorelli, S.14
-
6
-
-
0035915662
-
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma
-
DOI 10.1016/S0140-6736(00)03590-X
-
Vergote I, De Brabanter J, Fyles A, et al: Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 357: 176-182, 2001. (Pubitemid 32108089)
-
(2001)
Lancet
, vol.357
, Issue.9251
, pp. 176-182
-
-
Vergote, I.1
De Brabanter, J.2
Fyles, A.3
Bertelsen, K.4
Einhorn, N.5
Sevelda, P.6
Gore, M.E.7
Kaern, J.8
Verrelst, H.9
Sjovall, K.10
Timmerman, D.11
Vandewalle, J.12
Van Gramberen, M.13
Trope, C.G.14
-
7
-
-
0038648314
-
Long-term prognosis of stage I ovarian carcinoma: Prognostic importance of intraoperative rupture
-
DOI 10.1159/000071202
-
Mizuno M, Kikkawa F, Shibata K, Kajiyama H, Suzuki T, Ino K, Kawai M and Mizutani S: Long-term prognosis of stage I ovarian carcinoma. Prognostic importance of intraoperative rupture. Oncology 65: 29-36, 2003. (Pubitemid 36829088)
-
(2003)
Oncology
, vol.65
, Issue.1
, pp. 29-36
-
-
Mizuno, M.1
Kikkawa, F.2
Shibata, K.3
Kajiyama, H.4
Suzuki, T.5
Ino, K.6
Kawai, M.7
Mizutani, S.8
-
8
-
-
0032313535
-
The value of CA 125 and CA72-4 in management of patients with epithelial ovarian cancer
-
Fayed ST, Ahmad SM, Kassim SK and Khalifa A: The value of CA125 and CA72-4 in management of patients with epithelial ovarian cancer. Dis Markers 14: 155-160, 1998. (Pubitemid 29324911)
-
(1998)
Disease Markers
, vol.14
, Issue.3
, pp. 155-160
-
-
Fayed, S.T.1
Ahmad, S.M.2
Kassim, S.K.3
Khalifa, A.4
-
9
-
-
0030200820
-
Clinical value of CA125, CA19-9, CEA, CA72-4, and TPA in borderline ovarian tumor
-
DOI 10.1006/gyno.1996.0191
-
Tamakoshi K, Kikkawa F, Shibata K, et al: Clinical value of CA125, CA19-9, CEA, CA72-4, and TPA in borderline ovarian tumor. Gynecol Oncol 62: 67-72, 1996. (Pubitemid 26234547)
-
(1996)
Gynecologic Oncology
, vol.62
, Issue.1
, pp. 67-72
-
-
Tamakoshi, K.1
Kikkawa, F.2
Shibata, K.3
Tomoda, K.4
Obata, N.H.5
Wakahara, F.6
Tokuhashi, Y.7
Ishikawa, H.8
Kawai, M.9
Tomoda, Y.10
-
10
-
-
0042123650
-
A case of ovarian cancer with remote metastases, with emphasis on changes in tumor marker values
-
DOI 10.1016/S0090-8258(03)00265-8
-
Mikami M, Suzuki A, Takehara K, Komiyama S, Ishikawa M and Hirose T: A case of ovarian cancer with remote metastases, with emphasis on changes in tumor marker values. Gynecol Oncol 90: 462-465, 2003. (Pubitemid 36952047)
-
(2003)
Gynecologic Oncology
, vol.90
, Issue.2
, pp. 462-465
-
-
Mikami, M.1
Suzuki, A.2
Takehara, K.3
Komiyama, S.4
Ishikawa, M.5
Hirose, T.6
-
11
-
-
0034056018
-
Effects of paclitaxel on CA-125 serum levels in ovarian cancer patients
-
DOI 10.1006/gyno.1999.5699
-
Paulsen T, Marth C, Kaern J, Nustad K, Kristensen GB and Trope C: Effects of paclitaxel on CA-125 serum levels in ovarian cancer patients. Gynecol Oncol 76: 326-330, 2000. (Pubitemid 30131502)
-
(2000)
Gynecologic Oncology
, vol.76
, Issue.3
, pp. 326-330
-
-
Paulsen, T.1
Marth, C.2
Kaern, J.3
Nustad, K.4
Kristensen, G.B.5
Trope, C.6
-
12
-
-
0033385265
-
Ovarian cancer identified through screening with serum markers but not by pelvic imaging
-
DOI 10.1046/j.1525-1438.1999.99073.x
-
Woolas RP, Oram DH, Jeyarajah AR, Bast RC and lacobs II: Ovarian cancer identified through screening with serum markers, but not by pelvic imaging. Int J Gynecol Cancer 9: 497-501, 1999. (Pubitemid 30027555)
-
(1999)
International Journal of Gynecological Cancer
, vol.9
, Issue.6
, pp. 497-501
-
-
Woolas, R.P.1
Oram, D.H.2
Jeyarajah, A.R.3
Bast Jr., R.C.4
Jacobs, I.J.5
-
13
-
-
0028276724
-
An assessment of the value of serum CA 125 measurements in the management of epithelial ovarian carcinoma
-
DOI 10.1006/gyno.1994.1135
-
Gard GB and Houghton CR: An assessment of the value of serum CA 125 measurements in the management of epithelial ovarian carcinoma. Gynecol Oncol 53: 283-289, 1994. (Pubitemid 24187854)
-
(1994)
Gynecologic Oncology
, vol.53
, Issue.3
, pp. 283-289
-
-
Gard, G.B.1
Houghton, C.R.S.2
-
14
-
-
0027232425
-
Serum CA 125 level allows early identification of nonresponders during induction chemotherapy
-
DOI 10.1006/gyno.1993.1089
-
Makar AP, Kristensen GB, Bormer OP and Trope CG: Serum CA 125 level allows early identification of nonresponders during induction chemotherapy. Gynecol Oncol 49: 73-79, 1993. (Pubitemid 23148586)
-
(1993)
Gynecologic Oncology
, vol.49
, Issue.1
, pp. 73-79
-
-
Makar, A.P.1
Kristensen, G.B.2
Bormer, O.P.3
Trope, C.G.4
-
15
-
-
0022575599
-
The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer
-
Niloff JM, Knapp RC, Lavin PT, et al: The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer. Am J Obstet Gynecol 155: 56-60, 1986. (Pubitemid 16100526)
-
(1986)
American Journal of Obstetrics and Gynecology
, vol.155
, Issue.1
, pp. 56-60
-
-
Niloff, J.M.1
Knapp, R.C.2
Lavin, P.T.3
-
16
-
-
0021255763
-
Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen
-
Bast RC Jr, Klug TL, Schaetzl E, Lavin P, Niloff JM, Greber TF, Zurawski VR Jr and Knapp RC: Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen. Am J Obstet Gynecol 149: 553-559, 1984. (Pubitemid 14086185)
-
(1984)
American Journal of Obstetrics and Gynecology
, vol.149
, Issue.5
, pp. 553-559
-
-
Bast Jr., R.C.1
Klug, T.L.2
Schaetzl, E.3
-
17
-
-
16644397922
-
Predicting recurrence and metastasis of Dukes' A primary colorectal cancer with or without proper muscle invasion
-
Mukai M, Sato S, Ninomiya H, Kimura T, Komatsu N, Tajima T, Nakasaki H and Makuuchi H: Predicting recurrence and metastasis of Dukes' A primary colorectal cancer with or without proper muscle invasion. Oncol Rep 12: 1305-1308, 2004.
-
(2004)
Oncol Rep
, vol.12
, pp. 1305-1308
-
-
Mukai, M.1
Sato, S.2
Ninomiya, H.3
Kimura, T.4
Komatsu, N.5
Tajima, T.6
Nakasaki, H.7
Makuuchi, H.8
-
18
-
-
16644367914
-
Predicting recurrence and metastasis of stage III/Dukes' C colorectal cancer with lymph node metastasis
-
Mukai M, Sato S, Kimura T, Ninomiya H, Komatsu N, Tajima T, Nakasaki H and Makuuchi H: Predicting recurrence and metastasis of stage III/Dukes' C colorectal cancer with lymph node metastasis. Oncol Rep 12: 1301-1304, 2004.
-
(2004)
Oncol Rep
, vol.12
, pp. 1301-1304
-
-
Mukai, M.1
Sato, S.2
Kimura, T.3
Ninomiya, H.4
Komatsu, N.5
Tajima, T.6
Nakasaki, H.7
Makuuchi, H.8
-
19
-
-
21644452546
-
Accuracy of criteria for predicting recurrence and metastasis in stage II and III gastric cancer patients with lymph node metastasis
-
Mukai M, Sato S, Komatsu N, Kimura T, Ninomiya H, Kawada M, Nakasaki H, Ogoshi K and Makuuchi H: Accuracy of criteria for predicting recurrence and metastasis in stage II and III gastric cancer patients with lymph node metastasis. Oncol Rep 12: 63-66, 2004.
-
(2004)
Oncol Rep
, vol.12
, pp. 63-66
-
-
Mukai, M.1
Sato, S.2
Komatsu, N.3
Kimura, T.4
Ninomiya, H.5
Kawada, M.6
Nakasaki, H.7
Ogoshi, K.8
Makuuchi, H.9
-
20
-
-
21644483640
-
Criteria for predicting the recurrence and metastasis of stage I and II gastric cancer without lymph node metastasis
-
Mukai M, Sato S, Kimura T, Komatsu N, Ninomiya H, Nakasaki H, Ogoshi K and Makuuchi H: Criteria for predicting the recurrence and metastasis of stage I and II gastric cancer without lymph node metastasis. Oncol Rep 12: 59-62, 2004.
-
(2004)
Oncol Rep
, vol.12
, pp. 59-62
-
-
Mukai, M.1
Sato, S.2
Kimura, T.3
Komatsu, N.4
Ninomiya, H.5
Nakasaki, H.6
Ogoshi, K.7
Makuuchi, H.8
-
21
-
-
2642523935
-
Selection criteria for high risk and low risk groups of recurrence and metastasis in patients with primary colorectal cancer
-
Mukai M, Sato S, Nishida T, Komatsu N, Shiba K, Nakasaki H and Makuuchi H: Selection criteria for high risk and low risk groups of recurrence and metastasis in patients with primary colorectal cancer. Oncol Rep 10: 1753-1758, 2003.
-
(2003)
Oncol Rep
, vol.10
, pp. 1753-1758
-
-
Mukai, M.1
Sato, S.2
Nishida, T.3
Komatsu, N.4
Shiba, K.5
Nakasaki, H.6
Makuuchi, H.7
-
22
-
-
2142805213
-
Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with Dukes' C colorectal cancer
-
Mukai M, Sato S, Komatsu N, Nishida T, Shiba K, Ito I, Nakasaki H and Makuuchi H: Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with Dukes' C colorectal cancer. Oncol Rep 10: 1165-1169, 2003.
-
(2003)
Oncol Rep
, vol.10
, pp. 1165-1169
-
-
Mukai, M.1
Sato, S.2
Komatsu, N.3
Nishida, T.4
Shiba, K.5
Ito, I.6
Nakasaki, H.7
Makuuchi, H.8
-
23
-
-
39049174255
-
Enzyme-labeled antibodies: Preparation and application for localization of tissue antigens
-
Nakane PK and Pierce GB: Enzyme-labeled antibodies: preparation and application for localization of tissue antigens. J Histochem Cytochem 14: 929-931, 1966.
-
(1966)
J Histochem Cytochem
, vol.14
, pp. 929-931
-
-
Nakane, P.K.1
Pierce, G.B.2
-
24
-
-
0014087002
-
Enzyme-labeled antibody for the light and electron microscopic localization of tissue antigens
-
Nakane PK and Pierce GB: Enzyme-labeled antibody for the light and electron microscopic localization of tissue antigens. J Cell Biol 33: 307-318, 1967.
-
(1967)
J Cell Biol
, vol.33
, pp. 307-318
-
-
Nakane, P.K.1
Pierce, G.B.2
-
25
-
-
0028941741
-
The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer
-
Makar AP, Baekelandt M, Trope CG and Kristensen GB: The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer. Gynecol Oncol 56: 175-180, 1995.
-
(1995)
Gynecol Oncol
, vol.56
, pp. 175-180
-
-
Makar, A.P.1
Baekelandt, M.2
Trope, C.G.3
Kristensen, G.B.4
-
26
-
-
0027476280
-
The validity and significance of substages of advanced ovarian cancer
-
DOI 10.1006/gyno.1993.1040
-
Partridge EE, Gunter BC, Gelder MS, Alvarez RD, Soong SJ, Austin JM and Kilgore LC: The validity and significance of substages of advanced ovarian cancer. Gynecol Oncol 48: 236-241, 1993. (Pubitemid 23075179)
-
(1993)
Gynecologic Oncology
, vol.48
, Issue.2
, pp. 236-241
-
-
Partridge, E.E.1
Gunter, B.C.2
Gelder, M.S.3
Alvarez, R.D.4
Soong, S.-J.5
Austin, J.M.6
Kilgore, L.C.7
-
27
-
-
0025169845
-
Prognostic factors in patients with stage I epithelial ovarian cancer
-
Dembo AJ, Davy M, Stenwig AE, Berle EJ, Bush RS and Kjorstad K: Prognostic factors in patients with stage I epithelial ovarian cancer. Obstet Gynecol 75: 263-273, 1990. (Pubitemid 20062245)
-
(1990)
Obstetrics and Gynecology
, vol.75
, Issue.2
, pp. 263-273
-
-
Dembo, A.J.1
Davy, M.2
Stenwig, A.E.3
Berle, E.J.4
Bush, R.S.5
Kjorstad, K.6
-
28
-
-
0032754003
-
Long-term results and prognostic analysis in advanced and recurrent/refractory epithelial ovarian cancer treated by high-dose cyclophosphamide, adriamycin, and cisplatin with autologous bone marrow transplantation
-
Shinozuka T, Muramatsu T, Miyamoto, et al: Long-term results and prognostic analysis in advanced and recurrent/refractory epithelial ovarian cancer treated by high-dose cyclophosphamide, adriamycin, and cisplatin with autologous bone marrow transplantation. Int J Clin Oncol 4: 273-279, 1999.
-
(1999)
Int J Clin Oncol
, vol.4
, pp. 273-279
-
-
Shinozuka, T.1
Muramatsu, T.2
Miyamoto3
-
29
-
-
0027174820
-
Clear cell epithelial ovarian cancer (mesonephroid): Bad prognosis only in early stages
-
DOI 10.1006/gyno.1993.1117
-
O'Brien ME, Schofield JB, Tan S, Fryatt I, Fisher C and Wiltshaw E: Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages. Gynecol Oncol 49: 250-254, 1993. (Pubitemid 23170001)
-
(1993)
Gynecologic Oncology
, vol.49
, Issue.2
, pp. 250-254
-
-
O'Brien, M.E.R.1
Schofield, J.B.2
Tan, S.3
Fryatt, I.4
Fisher, C.5
Wiltshaw, E.6
-
30
-
-
3543082273
-
Occult neoplastic cells in the lymph node sinuses and recurrence of primary breast, lung, esophageal, and gastric cancer
-
Mukai M, Sato S, Nakasaki H, et al: Occult neoplastic cells in the lymph node sinuses and recurrence of primary breast, lung, esophageal, and gastric cancer. Oncol Rep 11: 81-84, 2004.
-
(2004)
Oncol Rep
, vol.11
, pp. 81-84
-
-
Mukai, M.1
Sato, S.2
Nakasaki, H.3
|